Eloira Hormonal Intrauterine system

Introduction

The Eloira Hormonal Intrauterine system is a contraceptive device that contains the active ingredient Levonorgestrel. It is a small, flexible T-shaped device that is inserted into the uterus by a healthcare professional. This intrauterine system is available under the brand name Eloira Hormonal Intrauterine system.

Uses

The Eloira Hormonal Intrauterine system is primarily used as a long-acting reversible contraceptive method. It provides effective contraception for up to 5 years and is suitable for women who desire long-term birth control. It can also be used to manage heavy menstrual bleeding.

Dosage and Administration

The Eloira Hormonal Intrauterine system is inserted into the uterus by a healthcare professional during an office visit. The procedure is typically performed within seven days of the start of the menstrual period. The device can be left in place for up to 5 years, after which it should be removed and replaced if continued contraception is desired.

Mechanism of Action

The active ingredient in the Eloira Hormonal Intrauterine system, Levonorgestrel, works by releasing a low dose of the hormone into the uterus. This hormone thickens the cervical mucus, making it difficult for sperm to reach the egg. It also thins the lining of the uterus, which may prevent the implantation of a fertilized egg.

Side Effects

Common side effects of the Eloira Hormonal Intrauterine system may include changes in menstrual bleeding patterns, such as lighter or heavier periods, irregular bleeding, or spotting between periods. Some women may experience abdominal pain, cramps, or backaches. These side effects are generally mild and tend to improve over time.

Serious side effects are rare, but they can include pelvic inflammatory disease (infection), perforation of the uterus during insertion, expulsion of the device, or ectopic pregnancy (pregnancy outside the uterus). If you experience severe abdominal pain, persistent bleeding, or suspect that the device has been expelled, seek immediate medical attention.

Drug Interactions

The Eloira Hormonal Intrauterine system has a localized effect in the uterus and does not interact with other medications in the same way as oral contraceptives. However, it is always important to inform your healthcare provider about all the medications, including over-the-counter drugs and herbal supplements, that you are taking to ensure there are no potential interactions.

Precautions

The Eloira Hormonal Intrauterine system may not be suitable for everyone. It is contraindicated in women with active pelvic inflammatory disease, current or past history of certain reproductive tract infections, uterine abnormalities, or certain types of cancer. Discuss your medical history with your healthcare provider before considering this contraceptive method.

Additionally, be aware that the Eloira Hormonal Intrauterine system does not protect against sexually transmitted infections (STIs). If you are at risk of STIs, it is recommended to use barrier methods, such as condoms.

Storage

Patient Tips

• It is normal to experience some discomfort or cramping during and after the insertion of the Eloira Hormonal Intrauterine system. Over-the-counter pain relievers can help alleviate these symptoms.
• Check the strings of the device regularly to ensure it is properly in place. If you cannot feel the strings or if they feel significantly shorter or longer than usual, contact your healthcare provider.
• If you experience persistent or severe pain, heavy bleeding, or any concerns about the device, contact your healthcare provider for further evaluation.
• The Eloira Hormonal Intrauterine system does not interfere with sexual intercourse and should not be felt by you or your partner during sex. If you experience any discomfort or pain during intercourse, consult your healthcare provider.
• Remember to schedule regular follow-up visits with your healthcare provider to ensure the continued effectiveness and proper placement of the device.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Benilexa One Handed 20 micrograms/24 hours Intrauterine Delivery System (Health Professionals SmPC) Available at:
• Levonorgestrel intrauterine system (Drugs.com) [Accessed 29 Jun. 2024] (online) Available at:
• estradiol-levonorgestrel patch, transdermal weekly (RX) [Accessed 3 Jun. 2024] (online) Available at:
• Levonorgestrel Intrauterine System (MedlinePlus) [Accessed 22 Jun. 2024] (online) Available at:
• Fotherby K. Levonorgestrel. Clinical pharmacokinetics. Clin Pharmacokinet. 1995 Mar;28(3):203-15. doi: 10.2165/00003088-199528030-00003. [Accessed 11 Jun. 2024] Available at: